These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20175748)

  • 1. The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
    Muirhead KE; Borger E; Aitken L; Conway SJ; Gunn-Moore FJ
    Biochem J; 2010 Feb; 426(3):255-70. PubMed ID: 20175748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
    Benek O; Musílek K; Kuca K
    Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
    Chen JX; Yan SD
    Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mitochondrial amyloid-beta in Alzheimer's disease.
    Chen JX; Yan SS
    J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde.
    Murakami Y; Ohsawa I; Kasahara T; Ohta S
    Neurobiol Aging; 2009 Feb; 30(2):325-9. PubMed ID: 17707551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial β-amyloid in Alzheimer's disease.
    Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
    Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi.
    Park HJ; Seong YM; Choi JY; Kang S; Rhim H
    Neurosci Lett; 2004 Feb; 357(1):63-7. PubMed ID: 15036614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of intracellular amyloid beta in Alzheimer's disease.
    Li M; Chen L; Lee DH; Yu LC; Zhang Y
    Prog Neurobiol; 2007 Oct; 83(3):131-9. PubMed ID: 17889422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small-molecule inhibitors of the Abeta-ABAD interaction.
    Xie Y; Deng S; Chen Z; Yan S; Landry DW
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
    Gouras GK; Almeida CG; Takahashi RH
    Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
    Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
    Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35).
    Kaminsky YG; Marlatt MW; Smith MA; Kosenko EA
    Exp Neurol; 2010 Jan; 221(1):26-37. PubMed ID: 19751725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.
    Du H; Yan SS
    Biochim Biophys Acta; 2010 Jan; 1802(1):198-204. PubMed ID: 19616093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain.
    Cotman SL; Halfter W; Cole GJ
    Mol Cell Neurosci; 2000 Feb; 15(2):183-98. PubMed ID: 10673326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.
    Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE
    Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.